Description
Retatrutide + Cagrilintide is a research peptide blend (Retatrutide 10mg + Cagrilintide 2.5mg) studied in laboratory settings for metabolic signaling pathways, GLP-1/GIP/glucagon receptor-related research, amylin receptor activity, appetite-regulation models, and glucose-metabolism research. Intended for laboratory and research use only.






Reviews
There are no reviews yet.